Literature DB >> 24187038

Management of metastatic bone disease of the acetabulum.

Paul S Issack, Suhel Y Kotwal, Joseph M Lane.   

Abstract

Metastatic acetabular disease can be severely painful and may result in loss of mobility. Initial management may consist of diphosphonates, narcotic analgesics, radiation therapy, protected weight bearing, cementoplasty, and radiofrequency ablation. Patients with disease affecting large weight-bearing regions of the acetabulum and with impending failure of the hip joint are unlikely to gain much relief from nonsurgical treatment and interventional procedures. The profound osteopenia of the acetabulum, limited healing potential of the fracture, and projected patient life span and function necessitate surgical techniques that provide immediate stable fixation to reduce pain and restore ambulatory function. Current reconstructive procedures, including cemented total hip arthroplasty, the saddle or periacetabular endoprosthesis, and porous tantalum implants, are based on the quality of remaining acetabular bone as well as the patient's level of function and general health. Well-executed acetabular reconstructions can provide durable hip joints with good pain relief and function.

Entities:  

Mesh:

Year:  2013        PMID: 24187038     DOI: 10.5435/JAAOS-21-11-685

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  13 in total

Review 1.  Minimally Invasive Stabilization Using Screws and Cement for Pelvic Metastases: Technical Considerations for the Pelvic "Screw and Glue" Technique.

Authors:  William B Lea; John C Neilson; David M King; Sean M Tutton
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

2.  Reinforced reconstruction: A technique for the treatment of periacetabular metastases.

Authors:  Gerard Chang; Taylor Paziuk; Tyler Henry; James Krieg; Scot Brown
Journal:  J Orthop       Date:  2021-09-01

3.  Combination acetabular radiofrequency ablation and cementoplasty using a navigational radiofrequency ablation device and ultrahigh viscosity cement: technical note.

Authors:  Adam N Wallace; Ambrose J Huang; Devin Vaswani; Randy O Chang; Jack W Jennings
Journal:  Skeletal Radiol       Date:  2015-09-26       Impact factor: 2.199

Review 4.  The best of both worlds - managing the cancer, saving the bone.

Authors:  Issam Makhoul; Corey O Montgomery; Dana Gaddy; Larry J Suva
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

5.  Joint-sparing reconstruction for extensive periacetabular metastases: Literature review and a novel minimally invasive surgical technique.

Authors:  Karla Teresa S Araneta; Maroun Rizkallah; Louis-Martin Boucher; Robert E Turcotte; Ahmed Aoude
Journal:  J Bone Oncol       Date:  2022-04-06       Impact factor: 4.491

6.  Reconstruction with iliac pedestal cup and proximal femur tumor prosthesis after wide resection of chondrosarcoma - 10-year follow-up results.

Authors:  Diogo Lino Moura; Rúben Fonseca; João Freitas; António Figueiredo; José Casanova
Journal:  Rev Bras Ortop       Date:  2016-12-30

7.  Percutaneous osteoplasty for the management of a pubic bone metastasis.

Authors:  Guan Shi; Hai Tang
Journal:  Orthopade       Date:  2019-08       Impact factor: 1.087

8.  Total hip arthroplasty with reconstruction of acetabulum through direct anterior approach for metastatic bone disease of acetabulum combined with pathological proximal femoral neck fracture: A case report.

Authors:  Hironori Ochi; Tatsuya Takagi; Tomonori Baba; Masahiko Nozawa; Sung-Gon Kim; Yuko Sakamoto; Suguru Kato; Yasuhiro Homma; Kazuo Kaneko; Muneaki Ishijima
Journal:  Trauma Case Rep       Date:  2021-02-26

9.  The Harrington plus reconstruction for pelvic and acetabular metastases.

Authors:  Mukai Chimutengwende-Gordon; Ross Coomber; Fidel Peat; Nadim Tarazi; Daud Chou; Andrew Carrothers
Journal:  J Bone Oncol       Date:  2022-02-03       Impact factor: 4.072

10.  Emerging Concepts in the Surgical Management of Peri-Acetabular Metastatic Bone Disease.

Authors:  Aaron Gazendam; Daniel Axelrod; David Wilson; Michelle Ghert
Journal:  Curr Oncol       Date:  2021-07-17       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.